-
The patient whose 12-lead ECG and rhythm strip is shown above had chest discomfort at the time this tracing was recorded. In light of this history, how do you interpret the tracing?
-
Terminally ill cancer patients who had end-of life discussions with their physician had better quality of life during their last week and their caregivers had an easier bereavement.
-
A new agent has been approved by the fda for the treatment of thrombocytopenia associated with chronic immune thrombocytopenia purpura (ITP).
-
Previously undiagnosed cancer is frequent in patients with an unprovoked VTE and is more often detected with an extensive cancer screening strategy than with a limited screening strategy.
-
Lubiprostone, the new drug for idiopathic constipation, improved PEG-based colonoscopy preparation.
-
Approximately 50% of b-cell function has been lost at the time of initial diagnosis of type 2 diabetes.
-
Estrogen treatment (but not estrogen given along with progestin) seems associated with gastro-esophageal reflux (GER) in postmenopausal women. Weight gain increases risk.
-
Clinical trials of pharmacotherapy to prevent progression of cognitive decline in those with mild cognitive impairment (MCI) have been disappointing; neither cholinesterase inhibitors (donepezil, rivastigmine, galantamine), vitamin E, nor COX-2 inhibitors has demonstrated any clinically meaningful benefit in placebo-controlled MCI trials.
-
The ECG shown above was obtained from a patient who was seen in the office with atypical chest pain. Is there cause for concern?
-
Some women with DVT may stop warfarin after six months; Vytorin and cancer; preventing recurrent stroke; and FDA news.
